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Abstract 
The article presents the results of studying the parameters of peripheral blood and the 
system of coagulation of patients with uterine fibroids. The analyzed data indicate the 
presence of a pronounced chronic inflammatory process, which is confirmed by the relevant 
indicators. The obtained results correlate with the data obtained by other authors. Since in the 
course of preliminary studies, the expediency of using the buccal epithelium to confirm the 
diagnosis of "uterine fibroids" has been determined, the blood system parameters have been 
confirmed once again confirm the high-visibility of this technique. 
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Introduction. Uterine fibroid is a benign tumor characterized by immature myocyte 
growth of the vascular wall. It’s the most common disease among women of reproductive age 
and is 10 to 30%. Among women with primary uterine fibroids first inspection appears from 1 
to 5% of subjects, including gynecologic patients and 35% [8]. Most often, this pathology 
occurs in women older than 35 years, the peak incidence is coming 35 - 45 years [6, 7]. 
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Modern understanding of the etiology and pathogenesis of uterine myoma is based on 
the achievements of cytogenetics, molecular biology, endocrinology, immunology, areas 
intercellular interactions [9, 10]. 
Today there are a large number of clinical laboratory and instrumental methods of 
diagnosis of uterine myoma. However, according to recent published data focusing on 
research buccal epithelium with uterine cancer because it has several advantages due to the 
fact that there is non-invasive, and is characterized by a highly convenient collection of 
material [11]. We conducted a study confirming the feasibility of implementing this method 
as diagnostic criterion gynecological pathologies, including uterine fibroids. 
To confirm the feasibility of this method is the aim of our study was to investigate 
changes in peripheral blood and coagulation system in patients with uterine fibroids. 
Materials and methods. The study was conducted in 80 patients with uterine cancer 
patients. The data was compared with standard parameters as follows: in cases where the 
patient's been mentioned a particular index in the normal range, it took the unit. If the index 
was above or below the normal value, found the percentage increase (or decrease) in respect 
of the normal value. 
Blood sampling was performed in the morning on an empty stomach. To study 
hemostasis was used citrate plasma poor in platelets and citrate plasma rich in platelets. 
Citrate plasma rich in platelets was obtained by centrifugation of citrate stabilized blood 
(blood + 3.8% sodium citrate at a ratio of 1: 9) at 1000 - 1500 rpm for 5 - 7 minutes. Citrate 
plasma poor in platelets was treated by double centrifugation: first receiving plasma rich in 
platelets, and then again centrifuged for 15 - 20 min at 4 ° C at 3000 - 4500 rpm. [1]. 
The study included peripheral blood definition: hemoglobin, color index, hematocrit, 
number of erythrocytes and leukocytes, ESR, leukocyte formula according to generally 
accepted methodological recommendations [5]. 
Definition of indicators characterizing the coagulation system was carried out 
according to methodical recommendations Z.S. Barkagan [2]. For a detailed assessment of 
hyper- or hypocoagulation was used a large number of hemostasis criteria for correct 
assessment of each part of complex enzymatic process: platelet count, activated partial 
thromboplastin time (APTT), prothrombin index, thrombin time, international normal ratio 
(INR), fibrinogen, time recalcification soluble fibrin monomer complex (RFMK), tolerance to 
heparin [1]. 
Since in this case the observation contains significant amounts of the same values was 
used nonparametric statistical criteria adjusted for continuity. [4] 
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Results and discussion. The results of research of peripheral blood and coagulation 
system are shown in the table. The largest deviation of all parameters is hemoglobin. In 
26.25% of cases the deviation of the index in any direction relative to the norm, while in 
17.5% of patients is observed shifts to a lower side, and at 8.75% - a higher (Table.). 
Table 
Changes in peripheral blood and hemostasis system in patients with uterine fibroids 
Indicators % of patients with 
deviation indicator 
in any direction 
relative to the norm 
% of patients with 
a lower rejection 
rate from the 
normal side 
% Of patients 
with a larger 
deviation of the 
norm side 
Hemoglobin 26,25 17,5 8,75 
Hematocrit 0 0 0 
Red blood cells 21,25 17,5* 3,75 
Color index 2,5 2,5 0 
White blood cells 10 3,75 6,25 
Stab neutrophils 7,5 0 7,5 
Segmented neutrophils 0 0 0 
Eosinophils 1,25 0 1,25 
Lymphocytes 10 6,25 3,75 
ESR 7,5 1,25 6,25 
Prothrombin index 0 0 0 
Fibrinogen 10 1,25 8,75 
RFMС 2,5 0 2,5 
Recalcification time 0 0 0 
MHC 0 0 0 
APTT 2,5 2,5 0 
Thrombine time 1,25 0 1,25 
Thrombocytes 2,5 1,25 1,25 
Tolerance to heparin 0 0 0 
 
Indicator erythrocytes also greatly cases (21, 25%) goes beyond the norm, while more 
often (17.5%) it decreased than increased (in 3.75% of cases). Thus, statistically significant 
value of this index is shifted downward relative to standards (as an indicator of hemoglobin). 
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Unlike indicators red blood cells, leukocytes and content changes in leukocyte formula 
was not significant deviation relative to normal (10% of cases), often upwards of the figure 
(in 6.25%). In particular, increased 7.5% in the number of cases of band neutrophils; 
decreases (in 6.25% of cases) lymphocytes. 
Indicator ESR often been raised (in 6.25% of cases), but this aspect was observed in a 
small number of cases. 
Regarding the indicators that characterize the hemostatic system found that fibrinogen 
content was more increased (to 8.75%) and generally deviated from the norm only 10%. 
Changes of other indicators showed changes in all phases hemocoagulation not observed. 
The data correlate with the results by other researchers and confirm the presence of 
chronic inflammation that is characteristic clinical symptoms of uterine myoma [3, 6, 7]. 
Conclusions: 
1. The analysis of peripheral blood and hemostasis system indicate the presence of the 
inflammatory process in patients with uterine myoma. 
2. The results obtained confirm the diagnosis and enable further study using patients as 
a diagnostic criterion buccal epithelium. 
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